<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03360123</url>
  </required_header>
  <id_info>
    <org_study_id>PRO17080173</org_study_id>
    <nct_id>NCT03360123</nct_id>
  </id_info>
  <brief_title>Comparison of Triazolam and Midazolam for Anxiolysis During Dental Treatment in the Pediatric Patient</brief_title>
  <official_title>Oral Anxiolysis for the Older Pediatric Patient-Which Medication is Preferred?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Pittsburgh</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Pittsburgh</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will evaluate the perceptions of the effects of two anxiolytic medications
      commonly used during dental treatment in patients weighing 40 kilograms or more.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Midazolam and nitrous oxide are commonly used in pediatric patients requiring anxiolysis
      during dental treatment. Triazolam and nitrous oxide are commonly used in adult patients
      requiring anxiolysis during dental treatment. The participants in this study are patients
      already scheduled for 2 sedation appointments to complete their dental treatment. The
      medications are both benzodiazepines that have similar risks, neither medication has greater
      adverse effects than the other. This study will evaluate the perceptions of the effects of
      the medications via a parent survey and chart review. The goal of the study is to determine
      which anxiolytic medication is perceived to provide a better sedation experience for older
      pediatric patients based on parent perception of the medication's effects and the patient's
      behavior during dental treatment.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 26, 2018</start_date>
  <completion_date type="Anticipated">May 2018</completion_date>
  <primary_completion_date type="Anticipated">May 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Parent Survey</measure>
    <time_frame>10 minutes</time_frame>
    <description>Parents will complete a 4 questions post-treatment survey after the 2nd dental appointment.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Behavior Assessment during dental treatment</measure>
    <time_frame>60-90 minutes</time_frame>
    <description>A chart review to assess patient behavior during treatment &amp; successful completion of treatment will be completed on secure Children's Hospital of Pittsburgh of UPMC computers and will identify the patient through a coding system that will provide no link to patient identifiers. Patient behavior will be assessed using the Frankl Behavioral Rating scale. The behavior assessment will occur during the pre-sedation period, dental treatment and recovery period, which in total will take approximately 60-90 minutes. Your child's level of cooperation, willingness to accept treatment and emotions will be documented. Successful completion of treatment is determined by whether or not the treatment plan for that appointment was completed.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Dental Anxiety</condition>
  <arm_group>
    <arm_group_label>Midazolam Hydrochloride 2Mg/mL Syrup</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The participants in this arm will receive midazolam+nitrous oxide at the 1st dental appointment.
Dosage: Midazolam: Midazolam HCl Syrup 0.5mg/kg (Max: 15mg) taken 10-15 minutes prior to dental treatment.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Triazolam 0.125 MG</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The participants in this arm will receive triazolam+nitrous oxide at the 1st dental appointment. Dosage: Triazolam: 0.125mg tablet taken 30 minutes prior to dental treatment.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Midazolam Hydrochloride 2Mg/mL Syrup</intervention_name>
    <description>Midazolam HCl Syrup 0.5mg/kg (Max: 15mg) taken 10-15 minutes prior to dental treatment.</description>
    <arm_group_label>Midazolam Hydrochloride 2Mg/mL Syrup</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Triazolam 0.125 MG</intervention_name>
    <description>Triazolam: 0.125mg tablet taken 30 minutes prior to dental treatment.</description>
    <arm_group_label>Triazolam 0.125 MG</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Weigh 40 kilograms or more.

          2. 2/4 or 3/4 Frankl Behavioral Rating at their evaluation appointment.

          3. Dental treatment that requires two sedation appointments. Dental treatment that
             requires sedation includes: fillings, crowns, pulpotomies and/or extractions.

          4. Between the ages of 7-17 years old.

        Exclusion Criteria:

          1. Patients taking any of the following medications will be excluded from the study:
             Atripia, cimetidine, diltiazem, erythromycin, fluconazole, grapefruit juice,
             isoniazid, itraconazole, ketoconazole, nefazodone, rifampicin, ritonavir, fusidic
             acid, idelalisisb, methadone, olanzapine, thalidomide and/or troleandomycin.

          2. Pregnant patients will be excluded.

          3. Patients that have HIV-1 that is being treated with a protease inhibitor will be
             excluded.

          4. Patients with a MTHFR mutation will be excluded.

          5. Patients with acute narrow angle glaucoma will be excluded.

          6. Patients that have had a previous adverse, paradoxical or allergic reaction to any
             benzodiazepines will be excluded from the study.

          7. Patients unable to swallow medication in tablet form.

          8. Patients that do not speak English as their primary language.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>7 Years</minimum_age>
    <maximum_age>17 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Whitney Eichholz, DDS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Children's Hospital of Pittsburgh of UPMC</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Whitney Eichholz, DDS</last_name>
    <phone>8159785964</phone>
    <email>whitney.eichholz@upmc.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Heather Baumhardt, DDS</last_name>
    <phone>4128552345</phone>
    <email>heather.baumhardt@chp.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Children's Hospital of Pittsburgh of UPMC</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15224</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Heather Baumhardt, DDS</last_name>
      <phone>412-692-7543</phone>
      <email>heather.baumhardt@chp.edu</email>
    </contact>
    <contact_backup>
      <last_name>Alene D'Alesio, DMD</last_name>
      <phone>4126927543</phone>
      <email>alene.d'alesio@chp.edu</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Berthold CW, Schneider A, Dionne RA. Using triazolam to reduce dental anxiety. J Am Dent Assoc. 1993 Nov;124(11):58-64. Review.</citation>
    <PMID>8227774</PMID>
  </reference>
  <reference>
    <citation>Coldwell SE, Awamura K, Milgrom P, Depner KS, Kaufman E, Preston KL, Karl HW. Side effects of triazolam in children. Pediatr Dent. 1999 Jan-Feb;21(1):18-25.</citation>
    <PMID>10029963</PMID>
  </reference>
  <reference>
    <citation>Kaufman E, Hargreaves KM, Dionne RA. Comparison of oral triazolam and nitrous oxide with placebo and intravenous diazepam for outpatient premedication. Oral Surg Oral Med Oral Pathol. 1993 Feb;75(2):156-64.</citation>
    <PMID>8426714</PMID>
  </reference>
  <reference>
    <citation>Raadal M, Coldwell SE, Kaakko T, Milgrom P, Weinstein P, Perkis V, Karl HW. A randomized clinical trial of triazolam in 3- to 5-year-olds. J Dent Res. 1999 Jun;78(6):1197-203.</citation>
    <PMID>10371242</PMID>
  </reference>
  <reference>
    <citation>Ehrich DG, Lundgren JP, Dionne RA, Nicoll BK, Hutter JW. Comparison of triazolam, diazepam, and placebo as outpatient oral premedication for endodontic patients. J Endod. 1997 Mar;23(3):181-4.</citation>
    <PMID>9594761</PMID>
  </reference>
  <reference>
    <citation>Dionne RA, Yagiela JA, Cot√© CJ, Donaldson M, Edwards M, Greenblatt DJ, Haas D, Malviya S, Milgrom P, Moore PA, Shampaine G, Silverman M, Williams RL, Wilson S. Balancing efficacy and safety in the use of oral sedation in dental outpatients. J Am Dent Assoc. 2006 Apr;137(4):502-13.</citation>
    <PMID>16637480</PMID>
  </reference>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 27, 2017</study_first_submitted>
  <study_first_submitted_qc>November 27, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">December 2, 2017</study_first_posted>
  <last_update_submitted>April 3, 2018</last_update_submitted>
  <last_update_submitted_qc>April 3, 2018</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 4, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Pittsburgh</investigator_affiliation>
    <investigator_full_name>Whitney Eichholz</investigator_full_name>
    <investigator_title>Pediatric Dental Resident</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Midazolam</mesh_term>
    <mesh_term>Triazolam</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

